Comparison of Prognostic Performance of 8th and 7th Edition of AJCC Staging System for Patients With Gallbladder Cancer Undergoing Curative Intent Surgery
Journal of Surgical Oncology · 2025-02 · 131 (2) · 220-231
DOI: 10.1002/jso.27875 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Surgical Oncology, online erschienen am 10.09.2024. Verfasst von Sameer Gupta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, King George's Medical University, Lucknow, India. Hauptthemen laut MEDLINE: Neoplasm Staging, Gallbladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
We compared the predictive performance of the 7th and 8th editions of the AJCC staging systems in stratifying disease‐related survival outcomes in patients with GBC undergoing curative intent surgery.
Methods
Patients that underwent curative intent surgery for GBC at our institution (2014 and 2021) were included in the study. Various clinico‐pathological data were extracted to perform Kaplan–Meier survival analysis.
Results
A total of 240 patients were included in the study. Both, TNM‐7, and TNM‐8 staging systems can stratify patients into stages with statistically significant differences in disease‐free and overall survival. Survival rates drop with stage progression. Using TNM‐8, 8/240 (3.33%) patients were upstaged from Stage IIIB (TNM‐7) to IVB (TNM‐8) and 12/240 (5%) were down‐staged from Stage IVB(TNM‐7) to IIIB(TNM‐8). Survival curves of the re‐classified patients matched those of the corresponding TNM‐8 stage. Additionally, there was statistically significant difference in their survival ( p < 0.001) compared to their corresponding TNM‐7 stage. There was no statistically significant difference in survival rates between stages IIA, IIB (TNM‐8), and stage II (TNM‐7). However, stage IIA had a slightly better survival than stage IIB.
Conclusion
Though both TNM‐7 and TNM‐8 are useful for stratifying patients with GBC, TNM‐8 has a better prognostic performance than TNM‐7.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, King George's Medical University, Lucknow, India.
- Vice-Chancellor, Atal Bihari Vajpayee Medical University, Lucknow, India.
- Department of Pathology, King George's Medical University, Lucknow, India.
- Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Surgery, Fred and Pamela Buffett Cancer Center, Division of Surgical Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Zitieren
APA
Gupta, S., Verma, A., Chaturvedi, A., Prakash, P., Kumar, V., Misra, S., Akhtar, N., Rajan, S., Agarwal, P., Smith, L., Schissel, M., & Are, C. (2025). Comparison of Prognostic Performance of 8th and 7th Edition of AJCC Staging System for Patients With Gallbladder Cancer Undergoing Curative Intent Surgery. Journal of Surgical Oncology, 131(2), 220-231. https://doi.org/10.1002/jso.27875
Vancouver
Gupta S, Verma A, Chaturvedi A, Prakash P, Kumar V, Misra S, et al. Comparison of Prognostic Performance of 8th and 7th Edition of AJCC Staging System for Patients With Gallbladder Cancer Undergoing Curative Intent Surgery. Journal of Surgical Oncology. 2025;131(2):220-231. doi:10.1002/jso.27875
BibTeX
@article{Gupta2025,
author = {Gupta, Sameer and Verma, Abhishek and Chaturvedi, Arun and Prakash, Puneet and Kumar, Vijay and Misra, Sanjeev and Akhtar, Naseem and Rajan, Shiv and Agarwal, Preeti and Smith, Lynette and Schissel, Makayla and Are, Chandrakanth},
title = {Comparison of Prognostic Performance of 8th and 7th Edition of AJCC Staging System for Patients With Gallbladder Cancer Undergoing Curative Intent Surgery},
journal = {Journal of Surgical Oncology},
year = {2025},
volume = {131},
number = {2},
pages = {220--231},
doi = {10.1002/jso.27875}
}
EUVIMED